for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Yield10 Bioscience Inc

YTEN.O

Latest Trade

--

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

--

 - 

--

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest News

BRIEF-Yield10 Bioscience Reports Q1 Loss Per Share $0.24

* YIELD10 BIOSCIENCE ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Yield10 Bioscience Reports Q4 Loss Per Share Of $0.99

* YIELD10 BIOSCIENCE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Yield10 Bioscience Announces Pricing Of $12.6 Mln Public Offering

* YIELD10 BIOSCIENCE ANNOUNCES PRICING OF $12.6 MILLION PUBLIC OFFERING

BRIEF-Yield10 Bioscience Grants Research License To Monsanto To Evaluate Two Novel Yield Traits In Soybean

* YIELD10 BIOSCIENCE INC - GRANTED A NON-EXCLUSIVE RESEARCH LICENSE TO MONSANTO COMPANY TO EVALUATE ITS NOVEL C3003 AND C3004 YIELD TRAITS IN SOYBEAN

BRIEF-Yield10 Bioscience posts Q3 loss $0.59/shr from continuing operations

* Yield10 Bioscience announces third quarter 2017 financial results

BRIEF-‍Yield10 Bioscience obtains confirmation of nonregulated status from USDA-APHIS for its genome-edited Camelina line​

* Yield10 bioscience obtains confirmation of nonregulated status from USDA-APHIS for its genome-edited Camelina line Source text for Eikon: Further company coverage:

BRIEF-Yield10 Bioscience Q2 loss per share $0.96 from continuing operations

* Yield10 Bioscience announces second quarter 2017 financial results

BRIEF-Yield10 Bioscience announces pricing of $2.3 mln registered direct offering

* Yield10 Bioscience announces pricing of $2.3 million registered direct offering

BRIEF-Yield10 Bioscience announces 1-for-10 reverse stock split

* Yield10 Bioscience Inc says company's common stock will begin trading on a split-adjusted basis on Tuesday, May 30, 2017 Source text for Eikon: Further company coverage:

BRIEF-Yield10 Bioscience announces Q1 revenue $300,000

* Yield10 Bioscience announces first quarter 2017 financial results

BRIEF-Yield10 Bioscience files for mixed shelf of up to $25 mln

* Files for mixed shelf of up to $25 million - SEC filing Source text for Eikon: Further company coverage:

BRIEF-Yield10 Bioscience Q4 loss per share $0.06 from continuing operations

* Yield10 Bioscience announces fourth quarter and full year 2016 financial results

BRIEF-Yield10 Bioscience outlines plans for spring 2017 field tests of gene C3003

* Outlines plans for spring 2017 field tests of novel yield trait gene C3003 in Camelina and canola

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up